{"text": ["3", "Dividend", "Stocks", "for", "In-the-Know", "Investors"], "created_at": "2018-05-10 22:49:00"}
{"text": ["Exploring", "AbbVie\u2019s", "Cash", "Flows"], "created_at": "2018-05-10 16:42:04"}
{"text": ["What\u2019s", "AbbVie\u2019s", "Business", "Strategy", "for", "2018?"], "created_at": "2018-05-10 16:42:04"}
{"text": ["Analyzing", "AbbVie\u2019s", "Financial", "Performance"], "created_at": "2018-05-10 16:42:03"}
{"text": ["Exploring", "AbbVie\u2019s", "Research", "Programs", "in", "Oncology", "and", "Neurology"], "created_at": "2018-05-10 16:42:03"}
{"text": ["Exploring", "the", "Key", "Aspects", "of", "AbbVie\u2019s", "Research", "Pipeline"], "created_at": "2018-05-10 16:42:03"}
{"text": ["Analyzing", "AbbVie\u2019s", "Humira,", "Imbruvica,", "and", "HCV", "Products"], "created_at": "2018-05-10 16:42:02"}
{"text": ["Analyzing", "AbbVie\u2019s", "Product", "Performance"], "created_at": "2018-05-10 16:42:02"}
{"text": ["How", "Much", "Upside", "Do", "Analysts", "Expect", "from", "AbbVie?"], "created_at": "2018-05-10 16:42:01"}
{"text": ["Analysts\u2019", "Recommendations", "for", "Regeneron", "Pharmaceuticals", "in", "May"], "created_at": "2018-05-10 11:32:22"}
